Poster zum Thema "Spasticity"

Zurück
Attitudes and Practice Patterns of Canadian Physiatrists Surrounding Medical Cannabis
  • Karen Ethans (Winnipeg/ CA)
  • P 097
Which are the most frequently injected muscles in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in routine practice? Baseline data from the AboLiSh study
  • P 098
Immediate Effect Of Ultra Sound Guided Dry Needling in Spastic Soleus Muscle
  • P 099
Improved Disability and Quality of Life Outcomes in Hemiparetic Patients with Upper and Lower Limb Spasticity from Etiologies Other Than Stroke Treated with OnabotulinumtoxinA: Insights from the Adult Spasticity International Registry (ASPIRE) Study
  • P 100
Post Stroke Spasticity – An App for Self-Monitoring by Affected Patients
  • P 101
Feasibility data of different German questionnaires collecting information on comprehensibility and severity of three treatment-relevant symptoms of disabling spastic movement disorder after stroke
  • P 102
OnabotulinumtoxinA treatment and physician and patient satisfaction in patients with spastic hemiparesis from ASPIRE
  • P 103
Time duration to determine the optimal dose of botulinum toxin for the treatment of involuntary muscle hyperactivity in neurological disorders – Data analysis based on a botulinum toxin patient registry
  • P 104
Early, pro-active ,co-ordinated multidisciplinary management of severe spasticity in disorders of consciousness
  • P 105
Electrophysiological and Clinical Evaluation of the Effects of Anodal Transcutaneous Spinal Direct Current Stimulation (tsDCS) on Upper Extremity Spasticity in Chronic Stroke Patients: A Case Report
  • P 106
Early detection of spasticity in acute post-stroke patients
  • P 107
Is dry needling safe in stroke patients: a scoping review?
  • P 108
Multi-modal therapy in post-stroke elbow flexor spasticity: utility of botulinum toxin (BoNT) and casting to help hemiparetic gait patterns
  • P 109
Management of spasticity after stroke: Place of extracorporeal shock waves therapy (ESWT) in LMICs
  • P 110
Algo-dysfunctional syndrome in a patient with congenital spastic tetraparesis
  • P 111
Familial spastic paraparesis in Strümpell-Lorrain
  • P 114
Use of optokinetic chart stimulation based OKCSIB protocol to reduce upper limb spasticity and restore voluntary movements in chronic strokes and chronic traumatic brain injury: a retrospective case series.
  • P 115
Effects of Anodal Transcutaneous Spinal Direct Current Stimulation (tsDCS) on Spasticity and Adaptive Plasticity in Traumatic Quadriparesis: A Case Report
  • P 116
Role of diagnostic nerve block in evaluation and treatment of spastic equinovarus foot deformity
  • P 117
Rotation of the spine reduces spasticity (Rota-Therapy)
  • P 118
Multifocal Spasticity Treatment in Lower Limbs for People with Incomplete Spinal Cord Injury – A case series of bringing back old therapies
  • P 119
Botulin toxin type A in the management of lower-limb spasticity after traumatic spinal cord injury – Case series
  • P 120
Combination of Botulinum Toxin with Rehabilitation for Spasticity Management: A case series
  • P 121
Extracorporeal Shock Waves Therapy protocol in post-stroke triceps surae spasticity: A pilot randomised controlled trial
  • P 122
Real-World Clinical Utilization Differences of OnabotulinumtoxinA and AbobotulinumtoxinA in Upper Limb Spasticity
  • P 123
Single centre, prospective, observational study methodology to assess the use of GripAble, a rehabilitation device, on patients with upper limb spasticity (ULS) receiving botulinum toxin A (BoNT-A)
  • P 124
Design of a Global Inter-rater Reliability Study of the Post-stroke Spasticity Referral Tool
  • P 144
Management of spasticity and neuromuscular disorders in children with neuromuscular diseases
  • P 154
Management of hemifacial spasm by botulinum toxin in neurorehabilitation: Outcome and customer satisfaction
  • P 258
Tailoring interventions for meaningful client outcomes using a decision-making aid for upper limb neurorehabilitation: A multiple-case study series
  • P 331
A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)
  • P 336
Comparison of the effects on passive muscle stiffness between botulinum toxin injection and combined therapy of toxin injection and short leg cast in the children with spastic cerebral palsy
  • P 355
AbobotulinumtoxinA efficacy and safety in children with upper limb spasticity previously treated with botulinum toxin
  • P 438
Case report and literature review of osmotic demyelination syndrome presenting with dysphagia
  • P 446
The Cenral Neural Effects of Motor Control Exercise on Patients with Non-specific Chronic Low Back Pain：A Resting-State Functional Magnetic Resonance Imaging Study
  • P 451
Canadian physicians' practice patterns in the management of hemiplegic shoulder pain
  • P 496
Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population
  • P 530
The "PSS: early ID" application: Interactive features to engage providers in early identification and referral of patients with post-stroke spasticity